Title | Nanomedicine: Nanotechnology, Biology, and Medicine |
Abbreviation | Nanomed.: Nanotechnol. Biol. Med. |
Publication Type | Journal |
Subject Area, Categories, Scope | Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2) |
h-index | 151 |
Overall Rank/Ranking | 5564 |
SCImago Journal Rank (SJR) | 0.863 |
Impact Score | 4.51 |
Publisher | Elsevier Inc. |
Country | United States |
ISSN | 15499634, 15499642 |
Best Quartile | Q1 |
Coverage History | 2005-2023 |
Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is an international, peer-reviewed journal. Each quarterly issue of Nanomedicine: NBM presents basic, clinical, and engineering research in the field of nanomedicine. Article categories include basic, diagnostic, experimental, clinical, engineering, pharmacologic, and toxicologic nanomedicine. In addition, regular features will address the commercialization of nanomedicine advances, ethics in nanomedicine, funding opportunities, and other topics of interest to researchers and clinicians. We invite authors to submit original manuscripts and review articles.
Nanomedicine: Nanotechnology, Biology, and Medicine is a journal covering the technologies/fields/categories related to Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2). It is published by Elsevier Inc.. The overall rank of Nanomedicine: Nanotechnology, Biology, and Medicine is 5564. According to SCImago Journal Rank (SJR), this journal is ranked 0.863. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 151. The best quartile for this journal is Q1.
The ISSN of Nanomedicine: Nanotechnology, Biology, and Medicine journal is 15499634, 15499642. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Nanomedicine: Nanotechnology, Biology, and Medicine is cited by a total of 2335 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Nanomedicine: Nanotechnology, Biology, and Medicine is 4.51, which is computed in 2024 as per its definition. Nanomedicine: Nanotechnology, Biology, and Medicine IF is decreased by a factor of 1.26 and approximate percentage change is -21.84% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Nanomedicine: Nanotechnology, Biology, and Medicine is 4.51. If the same downward trend persists, Impact IF may fall in 2024 as well.
Year | Impact IF |
---|---|
2023/2024 | Coming Soon |
2023 | 4.51 |
2022 | 5.77 |
2021 | 6.23 |
2020 | 6.17 |
2019 | 5.57 |
2018 | 5.85 |
2017 | 6.79 |
2016 | 6.49 |
2015 | 6.81 |
2014 | 7.21 |
Nanomedicine: Nanotechnology, Biology, and Medicine has an h-index of 151. It means 151 articles of this journal have more than 151 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Nanomedicine: Nanotechnology, Biology, and Medicine is 15499634, 15499642. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Nanomedicine: Nanotechnology, Biology, and Medicine is 5564. According to SCImago Journal Rank (SJR), this journal is ranked 0.863. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Year | SJR |
---|---|
2023/2024 | Coming Soon |
2023 | 0.863 |
2022 | 0.899 |
2021 | 1.019 |
2020 | 1.263 |
2019 | 1.372 |
2018 | 1.508 |
2017 | 1.743 |
2016 | 1.687 |
2015 | 1.857 |
2014 | 1.876 |
Year | Ranking |
---|---|
2023/2024 | Coming Soon |
2023 | 5564 |
2022 | 4999 |
2021 | 3979 |
2020 | 3032 |
2019 | 2603 |
2018 | 2222 |
2017 | 1758 |
2016 | 1922 |
2015 | 1662 |
2014 | 1575 |
Nanomedicine: Nanotechnology, Biology, and Medicine is published by Elsevier Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 2005-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Nanomedicine: Nanotechnology, Biology, and Medicine is Nanomed.: Nanotechnol. Biol. Med.. This abbreviation ('Nanomed.: Nanotechnol. Biol. Med.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Nanomedicine: Nanotechnology, Biology, and Medicine latest impact IF is 4.51. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 7.21 (2014) and 4.51 (2023), respectively, in the last 10 years. Moreover, its average IS is 6.14 in the previous 10 years.
The Nanomedicine: Nanotechnology, Biology, and Medicine has an SJR (SCImago Journal Rank) of 0.863, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.876 in 2014 and the lowest being 0.863 in 2023. Furthermore, the average SJR of the Nanomedicine: Nanotechnology, Biology, and Medicine over the previous 10-year period stands at 6.14.
The latest h-index of the Nanomedicine: Nanotechnology, Biology, and Medicine is 151.
The Nanomedicine: Nanotechnology, Biology, and Medicine is published by the Elsevier Inc., with its country of publication being the United States.
The Nanomedicine: Nanotechnology, Biology, and Medicine is currently ranked 5564 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1575 in 2014 and its lowest position of 5564 in 2023.
The standard ISO4 abbreviation for the Nanomedicine: Nanotechnology, Biology, and Medicine is Nanomed.: Nanotechnol. Biol. Med..
Nanomedicine: Nanotechnology, Biology, and Medicine is classified as a journal that the Elsevier Inc. publishes.
The Nanomedicine: Nanotechnology, Biology, and Medicine encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Nanomedicine: Nanotechnology, Biology, and Medicine is assigned the following International Standard Serial Numbers (ISSN): 15499634, 15499642.
The best quartile for the Nanomedicine: Nanotechnology, Biology, and Medicine is Q1 (2023).
The Nanomedicine: Nanotechnology, Biology, and Medicine coverage history can be summarized as follows: 2005-2023.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
Applied Ecology and Environmental Research | journal | 18145 | Corvinus University of Budapest | 43 | 0.77 |
Criminal Justice Review | journal | 12054 | SAGE Publications Inc. | 42 | 1.10 |
Discourse | journal | 6196 | Routledge | 65 | 2.36 |
International Journal of Applied Linguistics | journal | 6241 | Wiley-Blackwell Publishing Ltd | 53 | 1.91 |
Modern Language Journal | journal | 1100 | Wiley-Blackwell | 112 | 3.93 |
Biological Procedures Online | journal | 4092 | BioMed Central Ltd | 48 | 3.54 |
Journal of Immigrant and Refugee Studies | journal | 8890 | Routledge | 36 | 2.04 |
Archiv fur Geflugelkunde | journal | 28770 | Verlag Eugen Ulmer | 30 | 0.00 |
SPE International Formation Damage Control Symposium Proceedings | conference and proceedings | 21934 | 16 | 0.00 | |
Rudarsko Geolosko Naftni Zbornik | journal | 13873 | 19 | 1.48 |
Year | Impact Score (IS) |
---|---|
2024/2025 | Coming Soon |
2023 | 4.51 |
2022 | 5.77 |
2021 | 6.23 |
2020 | 6.17 |
2019 | 5.57 |
2018 | 5.85 |
2017 | 6.79 |
2016 | 6.49 |
2015 | 6.81 |
2014 | 7.21 |